
12.80 Delayed Data As of Mar 24 | ![]() Today’s Change | 4.41 Today|||52-Week Range 14.75 | +93.94% Year-to-Date |
89bio (ETNB) Up 25% on Upbeat Data From Mid-Stage NASH Study Mar 23 / Zacks.com - Paid Partner Content | Merck's (MRK) Co-formulation Therapy Fails Lung Cancer Study Mar 17 / Zacks.com - Paid Partner Content |
BridgeBio Pharma (BBIO) Surges 77% YTD: Here's Why Mar 22 / Zacks.com - Paid Partner Content | Catalyst's (CPRX) Q4 Earnings & Sales Top, Boosted by Firdapse Mar 16 / Zacks.com - Paid Partner Content |
Altimmune (ALT) Stock Down Despite Positive Obesity Study Data Mar 22 / Zacks.com - Paid Partner Content | What Makes Avita Medical Inc. (RCEL) a Good Fit for 'Trend Investing' Mar 16 / Zacks.com - Paid Partner Content |
Karuna's (KRTX) KarXT Meets Primary Goal in Schizophrenia Study Mar 21 / Zacks.com - Paid Partner Content | How Much Upside is Left in Avita Medical Inc. (RCEL)? Wall Street Analysts Think 27.42% Mar 14 / Zacks.com - Paid Partner Content |
Esperion (ESPR) Plummets 54% Over Milestone Payment Row Mar 17 / Zacks.com - Paid Partner Content |
Previous close | 12.87 |
Today’s open | 12.60 |
Day’s range | 12.56 - 12.85 |
Volume | 1,946 |
Average volume (3 months) | 119,337 |
Market cap | $323.8M |
Earnings growth (last year) | +9.02% |
Earnings growth (this year) | -3.61% |
Earnings growth (next 5 years) | -3.12% |
Revenue growth (last year) | +17.75% |
P/E ratio | NM |
Price/Sales | 3.40 |
Price/Book | 3.81 |
Today’s change | Today’s % change | |
---|---|---|
VYGRVoyager Therapeutics... | -0.11 | -1.47% |
AUTLAutolus Therapeutics... | -0.05 | -2.67% |
BNGOBionano Genomics Inc | +0.01 | +0.92% |
STOKStoke Therapeutics I... | -0.22 | -2.80% |
Next reporting date | May 11, 2023 |
EPS forecast (this quarter) | -$0.27 |
Annual revenue (last year) | $34.4M |
Annual profit (last year) | -$26.7M |
Net profit margin | -77.47% |
Sector Health Technology |
Industry Medical Specialties |
No executives to display |
Corporate headquarters Valencia, California |